XML 243 R80.htm IDEA: XBRL DOCUMENT v3.22.1
Share capital - Schedule of reconciliation of the share capital (Details) - USD ($)
 1 Months Ended 12 Months Ended
Feb. 17, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of classes of share capital [line items]        
Beginning balance   $ 36,308,583 $ 36,277,477 $ 38,391,696
Shares issued   38,341,407 22,051,803 8,681,103
Share based payments   7,443,931 9,426,961 551,135
Share options exercised     59,562 12,082,930
Lucid acquisition   7,290,731    
Warrants exercised       71,461
Ending balance   54,131,038 36,308,583 36,277,477
Class A share capital        
Disclosure of classes of share capital [line items]        
Beginning balance   $ 151,588 $ 151,588 $ 151,588
Beginning balance (shares)   72 72 72
Ending balance   $ 151,588 $ 151,588 $ 151,588
Ending balance (shares)   72 72 72
Class B share capital        
Disclosure of classes of share capital [line items]        
Beginning balance   $ 103,056,538 $ 73,586,337 $ 51,093,434
Beginning balance (shares)   19,161,620 7,905,727 6,843,780
Shares issued   $ 38,341,407 $ 22,242,975 $ 8,681,103
Shares issued (shares)   15,480,462 8,925,942 408,651
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc       $ 12,361,657
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)       510,940
Share based payments $ 3,576,875 $ 3,751,412 $ 6,663,479 $ 1,340,929
Share-based payments (shares) 1,349,764 1,462,558 2,307,569 130,189
Share options exercised     $ 563,747  
Share options exercised (shares)     22,382  
Share cancellation (shares)   (156,278)    
Lucid acquisition   $ 7,023,732    
Lucid acquisition (shares)   4,502,392    
Warrants exercised       $ 109,214
Warrants exercised (shares)       12,167
Ending balance   $ 152,173,089 $ 103,056,538 $ 73,586,337
Ending balance (shares)   40,450,754 19,161,620 7,905,727
Warrants        
Disclosure of classes of share capital [line items]        
Beginning balance   $ 4,968,958 $ 4,321,989 $ 3,341,826
Beginning balance (shares)   6,749,109 467,451 546,212
Shares issued     $ 1,110,904 $ 0
Shares issued (shares)     6,335,758 0
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc       $ 1,420,407
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)       67,598
Share based payments   $ 98,513    
Share-based payments (shares)   100,000    
Lucid acquisition   $ 70,563    
Lucid acquisition (shares)   112,162    
Warrants exercised       $ (37,753)
Warrants exercised (shares)       (12,167)
Warrants expired   $ (617) $ (463,935) $ (402,491)
Warrants expired (shares)   (4,476) (54,100) (134,192)
Ending balance   $ 5,137,417 $ 4,968,958 $ 4,321,989
Ending balance (shares)   6,956,795 6,749,109 467,451